Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 3/2001

01-03-2001 | Original

Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial

Authors: F. Álvarez-Lerma, J. Insausti-Ordeñana, R. Jordá-Marcos, E. Maraví-Poma, A. Torres-Martí, J. Nava, A. Martínez-Pellús, M. Palomar, F. Barcenilla and the Spanish Collaborative Group for the Study of Severe Infections

Published in: Intensive Care Medicine | Issue 3/2001

Login to get access
Metadata
Title
Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial
Authors
F. Álvarez-Lerma
J. Insausti-Ordeñana
R. Jordá-Marcos
E. Maraví-Poma
A. Torres-Martí
J. Nava
A. Martínez-Pellús
M. Palomar
F. Barcenilla and the Spanish Collaborative Group for the Study of Severe Infections
Publication date
01-03-2001
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 3/2001
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s001340000846

Other articles of this Issue 3/2001

Intensive Care Medicine 3/2001 Go to the issue

Editorial

Acute respiratory distress syndrome of pulmonary and extra-pulmonary origin: fancy or reality?

Correspondence

Critical illness polyneuropathy in patients with systemic inflammatory response syndrome or septic shock

Experimental

Effects of nicotinamide, an inhibitor of PARS activity, on gut and liver O2 exchange and energy metabolism during hyperdynamic porcine endotoxemia

Correspondence

Severe aortic stenosis and reduced ejection fraction: intensive care treatment

Original

Elevation of creatine kinase in acute severe asthma is not of cardiac origin

Experimental

Abdomen release in prone position does not improve oxygenation in an experimental model of acute lung injury